The prettiest 20-weeks pregnant woman I've ever seen! |
People are justifiably concerned about the safety of
vaccines during pregnancy. In response to my post
on tetanus, I received a request
to provide studies on the safety of tetanus, diphtheria, and acellular
pertussis vaccines (Tdap) during pregnancy.
The data and studies that support the Advisory Committee on
Immunization Practice (ACIP) recommendations are
found in the recommendations themselves. These are published in the CDC's Morbidity and Mortality Weekly Report (MMWR).
Be forewarned: they're not easy to read.
As I wrote in my response to anonymous, the ACIP recommendations
for use of Tdap in pregnant women cited two studies (Gall et al., 2011 and Talbot
et al., 2010) that "did not suggest
any elevated frequency or unusual patterns of adverse events in pregnant women
who received Tdap"
The ACIP examined the
safety of Tdap in pregnancy in detail in a previous
recommendation.
The safety of tetanus toxoid vaccines in pregnancy was first
evaluated in the 1960's and the safety of diphtheria vaccine in pregnancy was evaluated
in the 1970's. Since the mid 1970's, the World Health Organization (WHO) Expanded Programme on
Immunizations (EPI) has included a recommendation for the use of tetanus
toxoid in pregnant women to prevent neonatal
tetanus. Since the early 1980's, the CDC and American College of
Obstetricians and Gynecologists have recommended
tetanus and diphtheria vaccine (Td) for under-immunized pregnant women.
Both tetanus toxoid and diphtheria toxoid vaccines, together
and separately, have over 30 years of safe use during pregnancy.
There were several studies of whole cell pertussis vaccines
in pregnancy in the 1930's and 1940's. No serious adverse reactions in either
mother or baby were recorded. Remember that whole-cell pertussis vaccines have around
3,000 antigens compared to the Tdap
vaccines currently licensed in the U.S. which contain only three or five inactivated
pertussis toxins.
In their General
recommendations on immunization, the ACIP states, "Risk to a developing fetus from vaccination of the mother during
pregnancy is theoretical. No evidence exists of risk to the fetus from
vaccinating pregnant women with inactivated virus or bacterial vaccines or
toxoids." The American College of Obstetricians and Gynecologists echoes
that statement in their Update
of immunization and pregnancy: Tdap.
ACOG
also states, "Ideally, vaccines
should be administered before conception." For reasons other than
concern about the safety of the vaccine during pregnancy, Holly received her
Tdap in 2008.
Additional information:
-
Centers for Disease Control and Prevention: Guidelines for Vaccinating
Pregnant Women
-
Immunization Action Coalition: Tetanus Vaccine
Questions and Answers
- National Network for Immunization Information: Vaccines for Pregnant Women
American College of Obstetricians and Gynecologists. (2012).
Update on immunization and pregnancy: tetanus, diphtheria, and pertussis
vaccination. Obstetrics and Gynecology,
119(3), 690-691. http://www.acog.org/Resources_And_Publications/Committee_Opinions/Committee_on_Obstetric_Practice/Update_on_Immunization_and_Pregnancy_Tetanus_Diphtheria_and_Pertussis_Vaccination.
Centers for Disease Control and Prevention. (1983).
Recommendations of the Immunization Practices Advisory Committee general
recommendations on immunizations. Morbidity
and Mortality Weekly Report, 32(1), 13-17. http://www.cdc.gov/mmwr/preview/mmwrhtml/00001226.htm.
Centers for Disease Control and Prevention. (2008).
Prevention of pertussis tetanus, and diphtheria among pregnant and postpartum
women and their infants. Morbidity and
Mortality Weekly Report, 57(4), 1-47, 51. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5704a1.htm.
Centers for Disease Control and Prevention (2011). General
recommendations on immunizations. Recommendations of the Advisory Committee on
Immunization Practices (ACIP). Morbidity
and Mortality Weekly Report, 60(2), 1-60. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6002a1.htm.
Centers for Disease Control and Prevention. (2011). Updated
recommendations for use of tetanus toxoid, reduced diphtheria toxoid and
acellular pertussis vaccine (Tdap) in pregnant women and persons who have or
anticipate having close contact with an infant aged <12 months – Advisory
Committee on Immunization Practices (ACIP), 2011. Morbidity and Mortality Weekly Report, 60(41), 1424-1426. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6041a4.htm.
Edwards, K. M. & Decker, M. D. (2008) Pertussis
vaccines. In S. A. Plotkin, W. A. Orenstein, & P. A. Offit (Eds.) Vaccines (5th Ed.). [Electronic
version].
Gall, S. A., Myers, J., & Pichichero, M. (2011).
Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on
maternal and neonatal serum antibody levels. American Journal of Obstetrics & Gynecology, 204(4), 334.e1-5.
doi.org/10.1016/j.ajog.2010.11.024.
Offit, P. A., Quarles, J., Gerber, M. A., Hackett, C. J.,
Marcuse, E. K., Kollman, T. R. et al. (2002). Addressing parents’ concerns: do
multiple vaccines overwhelm or weaken the infants immune system? Pediatrics, 109(1), 124-129. http://pediatrics.aappublications.org/content/109/1/124.full.
Talbot, E. A., Brown, K. H., Kirkland, K. B., Baughman, A.
L., Halperin, S. A., & Broder, K. R. (2010). The safety of immunizing with
tetanus-diphtheria-acellular pertussis vaccine (Tdap) less than 2 years
following a previous tetanus vaccination: experience during a mass vaccination
campaign of healthcare personnel during a respiratory illness outbreak. Vaccine, 28(50), 8001-8007. doi:10.1016/j.vaccine.2010.09.034.
Wassilak, S. G. F., Roper, M. H., Kretsinger, K., Orenstein,
W. A. (2008). Tetanus toxoid. In S. A. Plotkin, W. A. Orenstein, & P. A.
Offit (Eds) Vaccines (5th Ed.).
[Electronic version].
No comments:
Post a Comment